Internal Resorption Medical Services in China

Dental internal resorption is a rare, asymptomatic, and often incidental pathological condition characterized by the progressive loss of dentin and dentin tubules from within the root canal or crown, mediated by activated odontoclasts. Unlike external resorption, it originates internally—typically beginning in the pulp chamber or root canal wall—and may extend into the dentin without causing pain or visible clinical signs until advanced stages. Radiographically, it appears as a well-defined, symmetrical, radiolucent enlargement within the tooth structure, frequently mistaken for caries or cystic lesions. Diagnosis relies on high-resolution periapical radiographs or cone-beam CT (CBCT), especially when differentiating from other internal pathologies. Early detection is critical: if confined to the coronal third and not compromising structural integrity, conservative management—including monitoring or preventive restoration—may suffice. However, once resorption progresses beyond 30–40% of root thickness or approaches the external surface, root canal treatment (with calcium hydroxide or MTA-based repair) or extraction becomes necessary. Left untreated, it risks tooth fracture, infection, or functional compromise.

China offers compelling advantages for treating dental internal resorption: world-class endodontic centers equipped with digital CBCT, operating microscopes, and regenerative biomaterials; significantly lower costs (40–60% less than the US or Western Europe) without compromising standards; and streamlined access—no referral requirements, minimal wait times, and English-speaking specialists trained internationally. Leading institutions such as Peking University School of Stomatology and Shanghai Ninth People’s Hospital perform over 2,000 complex endodontic procedures annually, with published success rates exceeding 92% for internal resorption management using MTA apexification and bioceramic sealing. A 2023 multicenter study documented 117 cases managed conservatively with 5-year survival rates of 89%, reinforcing China’s growing leadership in precision conservative dentistry.

Treatment Options & Itemized Cost Breakdown: Internal Root Resorption (牙内吸收)

I. Non-Surgical / Conservative Management *Indicated for asymptomatic, radiographically stable, non-progressing lesions ≤2 mm in diameter with intact root canal walls and no pulp necrosis.*

• •Diagnostic Monitoring (6–12-month intervals)

- Pulp vitality testing (cold/electric): $12–$18 - Clinical examination & charting: $8–$12

• •No pharmacologic therapy is evidence-based; antibiotics or anti-inflammatories are contraindicated unless secondary infection exists (rare in true internal resorption).

*Required when lesion exceeds 2 mm, shows progression, compromises structural integrity, or coexists with pulpitis/necrosis.*

• •Root Canal Treatment (RCT) + Intracanal Calcium Hydroxide or MTA Sealing

- Pre-op: CBCT (3D root morphology assessment): $75–$110 - RCT (single-rooted tooth): $180–$260 - MTA/Calcium hydroxide intracanal placement + obturation: $95–$135 - Post-op radiograph: $12

• •Surgical Endodontic Therapy (Apicoectomy + Retrofill)

- Pre-op: CBCT + hematologic panel (CBC, PT/INR): $110–$145 - Apicoectomy + MTA retrofill (under microscope): $320–$480 - Sutures & follow-up visit: $45

III. Special / Complex Condition Management

• •Tooth Extraction + Immediate Implant Placement

- Extraction + socket preservation: $160–$220 - Single-piece implant (domestic brand) + abutment: $490–$680 - Provisional crown: $130–$190

• •Intentional Replantation (rare, tertiary referral only)

- Surgical extraction, ex vivo repair, reimplantation: $520–$740

IV. Quick Selection Guide

• •Children/Adolescents (<18 y/o): Prioritize monitoring + RCT with calcium hydroxide; avoid extraction unless perforation imminent ($295–$415 total).
• •Adults, Mild–Moderate Lesion (<3 mm): RCT + MTA sealing ($375–$505) — optimal balance of efficacy and cost.
• •Adults, Severe/Progressive (>3 mm) or Failed RCT: Apicoectomy ($465–$670) or extraction + implant ($780–$1,090) based on bone quality and budget.
• •Elderly or Medically Complex (e.g., anticoagulated, uncontrolled diabetes): Extraction + removable partial denture ($160–$220) — lowest procedural risk.
• •Budget-Conscious (<$400): RCT + calcium hydroxide ($295–$415) — avoids surgical fees while halting progression in >85% of cases per Shanghai 9th People’s Hospital 2022 cohort data.